Clinical experiences with vecuronium in children.

J Indian Med Assoc

Department of Anaesthesiology, Medical College and Hospitals, Calcutta.

Published: May 1991

The neuromuscular blocking effects of vecuronium have been investigated clinically in children regarding its efficacy and safety. The drug is given either of the two doses--0.08 mg/kg body weight or 0.1 mg/kg body weight in 40 children as a single intravenous bolus injection for endotracheal intubation. Vecuronium in doses of 0.1 mg/kg body weight provided satisfactory clinical relaxation for ideal intubating conditions in all children in reference to the ease of intubation, intermediate duration of action, spontaneous or easy reversal of the neuromuscular block, cardiovascular stability and absence of serious side-effects. Thus vecuronium may be regarded as a useful muscle relaxant in paediatric anaesthesia.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mg/kg body
12
body weight
12
clinical experiences
4
vecuronium
4
experiences vecuronium
4
children
4
vecuronium children
4
children neuromuscular
4
neuromuscular blocking
4
blocking effects
4

Similar Publications

Background: Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss, Lewy body build-up, and motor dysfunction. One of the primary pathogenic mechanisms of PD development is autophagy dysfunction and nitric oxide-mediated neurotoxicity.

Purpose: The current study focuses on autophagy and nitric oxide (NO) signaling roles in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated PD mice and their protection by their modulators.

View Article and Find Full Text PDF

Purpose: This randomized, controlled trial aimed to assess the sedative effects of esketamine and sufentanil combined with propofol during EUS.

Patients And Methods: Three hundred and forty patients undergone EUS were randomly divided into two groups to receive esketamine 0.25 mg/kg combined with propofol (esketamine group) or sufentanil 0.

View Article and Find Full Text PDF

Objective: The present study aims to explore the initial dosage optimization of sertraline in pediatric major depressive disorder (MDD) patients based on model-informed precision dosing (MIPD).

Methods: A total of 111 pediatric MDD patients treated with sertraline were included for analysis using MIPD. Sertraline concentration levels, physiological and biochemical indexes of pediatric MDD patients, combined drug information were included in the construction of model.

View Article and Find Full Text PDF

Significance: Women are at increased risk for mood disorders, which may be partly attributed to exposure to endocrine-disrupting chemicals (EDCs) during sensitive periods such as pregnancy. Exposure during these times can impact brain development in the offspring, potentially leading to mood disorders in later life. Additionally, fluctuating levels of endogenous estrogens, as seen during pregnancy, or the use of oral contraceptives, can further elevate this risk.

View Article and Find Full Text PDF

Background: Rheumatoid arthritis (RA) is a long-term inflammatory autoimmune disease that damages cartilage and synovial membranes while also affecting bones and joints. The aim of the current study was to investigate the antiarthritic effect of gossypin against collagen-induced arthritis (CIA) in rats.

Methods: Intraperitoneal administration of Type II collagen (2 mg/mL) was used to induce arthritis in the rats, followed by oral administration of gossypin (5, 10 and 15 mg/kg) for 28 days.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!